Tredje AP fonden raised its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 19.7% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 55,986 shares of the pharmacy operator’s stock after purchasing an additional 9,221 shares during the period. Tredje AP fonden’s holdings in Walgreens Boots Alliance were worth $2,146,000 as of its most recent SEC filing.
Several other hedge funds have also added to or reduced their stakes in the company. Private Ocean LLC bought a new position in shares of Walgreens Boots Alliance during the first quarter valued at $25,000. Islay Capital Management LLC purchased a new stake in Walgreens Boots Alliance during the 4th quarter valued at about $29,000. Americana Partners LLC purchased a new stake in Walgreens Boots Alliance during the 4th quarter valued at about $29,000. Pearl River Capital LLC bought a new stake in Walgreens Boots Alliance during the 1st quarter valued at about $35,000. Finally, Bray Capital Advisors purchased a new position in Walgreens Boots Alliance in the first quarter worth about $37,000. Hedge funds and other institutional investors own 58.03% of the company’s stock.
NASDAQ:WBA traded down $0.15 on Friday, hitting $39.60. The stock had a trading volume of 3,378,765 shares, compared to its average volume of 7,383,946. The business’s 50-day simple moving average is $42.22 and its two-hundred day simple moving average is $51.33. The stock has a market cap of $34.87 billion, a price-to-earnings ratio of 6.87, a price-to-earnings-growth ratio of 1.83 and a beta of 0.55. Walgreens Boots Alliance Inc has a 52-week low of $36.65 and a 52-week high of $64.50. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 1.34.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, April 2nd. The pharmacy operator reported $1.52 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.46 by $0.06. The firm had revenue of $35.82 billion for the quarter, compared to analysts’ expectations of $35.24 billion. Walgreens Boots Alliance had a net margin of 2.52% and a return on equity of 21.26%. The business’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.64 EPS. As a group, equities research analysts anticipate that Walgreens Boots Alliance Inc will post 5.53 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Wednesday, May 20th will be given a $0.4575 dividend. The ex-dividend date of this dividend is Tuesday, May 19th. This represents a $1.83 annualized dividend and a yield of 4.62%. Walgreens Boots Alliance’s payout ratio is presently 30.55%.
Several equities research analysts recently weighed in on WBA shares. UBS Group raised shares of Walgreens Boots Alliance from a “sell” rating to a “neutral” rating and reduced their price target for the company from $49.00 to $44.00 in a research report on Monday, April 6th. Royal Bank of Canada cut their target price on Walgreens Boots Alliance from $57.00 to $48.00 and set a “sector perform” rating on the stock in a research note on Friday, April 3rd. Deutsche Bank upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating and decreased their price target for the stock from $51.00 to $43.00 in a research note on Friday, April 3rd. SunTrust Banks dropped their price objective on Walgreens Boots Alliance from $58.00 to $42.00 and set a “hold” rating on the stock in a research report on Friday, April 3rd. Finally, Wells Fargo & Co reiterated a “hold” rating on shares of Walgreens Boots Alliance in a report on Thursday, April 2nd. Four analysts have rated the stock with a sell rating and thirteen have given a hold rating to the stock. Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus price target of $51.21.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Further Reading: What is the balance sheet?
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.